Cargando…
Fit-for-purpose quantitative liquid biopsy based droplet digital PCR assay development for detection of programmed cell death ligand-1 (PD-L1) RNA expression in PAXgene blood samples
Development of a clinically applicable liquid biopsy-based test for PD-L1 mRNA expression would be beneficial in providing complementary evidence to current immunohistochemistry assays. Hence, we report the development of a fit-for-purpose assay for detection of blood PD-L1 mRNA expression using dro...
Autores principales: | O’Rourke, Dennis, Wang, Danyi, Sanchez-Garcia, Jorge F., Cusano, Maria Perella, Miller, Waldemar, Cai, Ti, Scheuenpflug, Juergen, Feng, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109819/ https://www.ncbi.nlm.nih.gov/pubmed/33970922 http://dx.doi.org/10.1371/journal.pone.0250849 |
Ejemplares similares
-
Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients
por: Wang, Danyi, et al.
Publicado: (2021) -
Comparison of Two Illumina Whole Transcriptome RNA Sequencing Library Preparation Methods Using Human Cancer FFPE Specimens
por: Wang, Danyi, et al.
Publicado: (2022) -
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays
por: Wang, Danyi, et al.
Publicado: (2023) -
Histological Assessment of PAXgene Tissue Fixation and Stabilization Reagents
por: Kap, Marcel, et al.
Publicado: (2011) -
PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology
por: DeCoste, Ryan, et al.
Publicado: (2022)